Women in England with advanced breast cancer to receive Enhertu on NHS
The Guardian · September 17, 2026Original source ↗
What happened
Women in England with HER2-low advanced breast cancer will have access to the drug Enhertu through the NHS. Approximately 1,000 women annually will be able to obtain this medication following a successful price negotiation between the government and the drug's manufacturers.
Why it matters
This development provides new treatment options for women with incurable breast cancer in England.
How this story affects people
How does this story affect you if you are a woman in England with HER2-low advanced breast cancer?
You will now have access to Enhertu, a life-extending medication, through the NHS. This means you can potentially improve your treatment options and quality of life.
Want this written about you?
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Get your RippleMore stories
- HealthNew Mexico reports screwworm case in horse before livestock imports from Mexico resume
- HealthPentagon provides new guidance for testosterone testing for service members
- HealthRFK Jr. addresses conference for activist group he founded
- HealthAt least 48 fatalities in Nigeria linked to potentially toxic local alcohol